Christopher J. Twomey - 27 Oct 2026 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 Oct 2026, 16:06:46 UTC
Prior SEC filing
22 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jerilyn Laskie, Attorney-in-Fact for Christopher J. Twomey
Filing notes and source

Key filing fact

Christopher J. Twomey filed Form 4 for TANDEM DIABETES CARE INC (TNDM) on 29 Oct 2026.

Key facts

  • This page summarizes Christopher J. Twomey's Form 4 filing for TANDEM DIABETES CARE INC (TNDM).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 29 Oct 2026, 16:06.

Change

  • Previous filing in this sequence was filed on 22 May 2026.
  • Current net transaction value: -$32,555.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001238935 Primary reporting owner

TWOMEY CHRISTOPHER J

Relationship
Director
Address
12400 HIGH BLUFF DRIVE, SAN DIEGO
Signature
/s/ Jerilyn Laskie, Attorney-in-Fact for Christopher J. Twomey
Signature date
29 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNDM transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,700
Change %
+7%
Price
$19.00*
Shares after
26,134
Date
27 Oct 2026
Ownership
Direct
Footnotes
F1
TNDM transaction

Common Stock

Sale

Transaction value
-$32,555
Shares
-1,700
Change %
-6.5%
Price
$19.15
Shares after
24,434
Date
27 Oct 2026
Ownership
Direct
Footnotes
F2
TNDM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,568
Date
27 Oct 2026
Ownership
See Footnotes
Footnotes
F3
TNDM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,112
Date
27 Oct 2026
Ownership
See Footnote
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TNDM transaction Derivative

Stock Option

Options Exercise

Transaction value
Shares
-1,700
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,700
Exercise price
$19.00
Footnotes
F5, F6, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

Represents shares of common stock received upon exercise of a stock option award.

Footnote F2

The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2026.

Footnote F3

The securities are directly owned by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over these securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.

Footnote F4

The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.

Footnote F5

Awarded on November 15, 2016 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto.

Footnote F6

Such options became exercisable in 12 equal monthly installments beginning on December 15, 2016.

Footnote F7

Such options expire on November 15, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .